期刊文献+

安徽省结核病控制项目1997年病人化疗情况调查 被引量:3

A survey of patients receiving chemotherapy under Anhui provincial tuberculosis control program in 1997
下载PDF
导出
摘要 目的 了解结核病控制项目病人化疗情况。方法 抽取肥西、东至等9 个结核病控制项目县对1997 年全年发现的肺结核病人接受正规化疗情况进行调查,并对未按要求完成全程化疗的原因进行分析。结果 发现2 428 例肺结核病人,其中涂阳病人1 012 例,完成疗程925 例,占91.4% ,涂阴病人1 416 例,完成疗程1 046 例,占73.9% ,未能坚持完成疗程的原因主要为经济因素及结核病归口管理工作未落实。 Objective In order to survey patients receiving chemotherapy under Tuberculosis Control Program. Methods 9 program counties and 2 428 pulmonary patients who were found in 1997 were selected. The status of their chemotherapy were investigated and the reasons of imcomplete were analysed. Results Among 2 428 cases, 1 012 cases smear positive patients' chemotherapy complete rate was 91.4% and 1 416 cases smear negative patients' was 73.9%. The reasons of imcomplete chemothrapy were financial problem and the management of the transfer of all tuberculosis suspects and cases. Concolusion Strengthening management, transfering all tuberculosis suspects and cases and enhancing financial for antituberculosis were main measures for increasing chemotherapy complete rate.
出处 《中华疾病控制杂志》 CAS 1999年第3期188-189,共2页 Chinese Journal of Disease Control & Prevention
基金 卫生部加强与促进结核病控制项目
关键词 肺结核 预防和控制 pulmonary tuberculosis prevention and control
  • 相关文献

同被引文献19

  • 1赵大海,徐飚.结核病与贫穷[J].中国防痨杂志,2004,26(3):177-179. 被引量:42
  • 2邓斌,何庆伟,余锦香,周志刚,罗勇强,易来龙,张锡萍,邓恩东.初治肺结核治愈后复发危险因素COX比例风险模型研究[J].国际医药卫生导报,2005,11(17):28-30. 被引量:3
  • 3杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 4Jackson S,Sleigh AC,Wang GJ,et al.Poverty and the eco-nomic effects of TB in rural China.Int J Tuberc Lung Dis,2006,10(10):1104-1110.
  • 5Xu B,Dong HJ,Zhao Q,et al.DOTS in China-removing bar-riers or moving barriers?Health Policy Plan,2006,21(5):365-372.
  • 6Spence DP,Hotchkiss J,Williams CS,et al.Tuberculosis andpoverty.BMJ,1993,307:759-761.
  • 7王宇.全国第五次结核病流行病学抽样调查资料汇编.北京:军事医学科学出版社,2012:52-60.
  • 8World Health Organization.Guidelines for the programmaticmanagement of drug-resistant tuberculosis.Geneva:WorldHealth Organization,2008.
  • 9Rajbhandary SS,Marks SM,Bock NN.Costs of patients hos-pitalized for multidrug-resistant tuberculosis.Int J TubercLung Dis,2004,8(8):1012-1016.
  • 10Wilson LG.The historical decline of tuberculosis in Europeand America:its causes and significance.J Hist Med AlliedSci,1990,45(3):366-396.

引证文献3

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部